Lichen Planus Clinical Trial
Official title:
Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human
Lichen planus is a chronic cutaneous and mucosal disease characterized by the infiltration of cluster of differentiation (CD) CD8 T lymphocytes, localized under the basal membrane and associated with apoptosis of basal keratinocytes, suggesting a reactivity of T lymphocytes toward keratinocyte antigen(s), so far unidentified. In a recent study, the research team at Institut Pasteur has demonstrated in a peculiar clinical form of lichen planus (erosive lichen planus), that the immunogenic target of CD8 T lymphocytes could be the immunodominant peptide of Human Papilloma Virus (HPV) 16. In line with this recent work which shows for the first time a link between HPV-16 and an autoimmune disease, erosive lichen planus, the aim of te study is to test the hypothesis that HPV could be also involved in the pathogenesis of other clinical forms of lichen, such as non erosive lichen planus or lichen sclerosus.
Lichen planus is a chronic cutaneous and mucosal disease characterized by the infiltration of cluster of differentiation (CD) CD8 T lymphocytes, localized under the basal membrane and associated with apoptosis of basal keratinocytes, suggesting a reactivity of T lymphocytes toward keratinocyte antigen(s), so far unidentified. In a recent study, the research team at Institut Pasteur has demonstrated in a peculiar clinical form of lichen planus (erosive lichen planus), that the immunogenic target of CD8 T lymphocytes could be the immunodominant peptide of Human Papilloma Virus (HPV) 16. In line with this recent work which shows for the first time a link between HPV-16 and an autoimmune disease, erosive lichen planus, the aim of te study is to to test the hypothesis that HPV could be also involved in the pathogenesis of other clinical forms of lichen, such as non erosive lichen planus or lichen sclerosus. Regarding erosive lichen planus, the aim is to test the cytotoxic function of the previously identified CD8 T lymphocytes specific for HPV16 E711-20. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06021405 -
Koebner's Phenomenon in Psoriasis and Lichen Planus
|
N/A | |
Recruiting |
NCT03340155 -
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases
|
N/A | |
Completed |
NCT05787925 -
Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus
|
N/A | |
Completed |
NCT03630198 -
Pain Outcomes Following Intralesional Corticosteroid Injections
|
Phase 4 | |
Completed |
NCT04952961 -
Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
|
N/A | |
Recruiting |
NCT04697563 -
Laser Therapy in Women With Lichenoid Disorders
|
N/A | |
Recruiting |
NCT06451744 -
Cellular and Molecular Biomarkers in Patients With Lichen Planus
|
N/A | |
Completed |
NCT03265093 -
Use of Injectable Platelet Rich Fibrin in Lichen Planus
|
N/A | |
Completed |
NCT03858634 -
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases
|
Phase 2 | |
Active, not recruiting |
NCT00691106 -
A Multi-center Study to Evaluate the Safety of Etanercept in the Treatment of Lichen Planus
|
Phase 2 | |
Terminated |
NCT05761158 -
Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
|
||
Recruiting |
NCT02261662 -
Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection
|
N/A | |
Not yet recruiting |
NCT04892381 -
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
|
||
Completed |
NCT05396261 -
a Flexible Wound Dressing for the Management of Genital Skin Conditions
|
N/A | |
Recruiting |
NCT02532166 -
Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus
|
N/A | |
Recruiting |
NCT06327620 -
Treatment Of Oral Lichen Planus
|
N/A | |
Completed |
NCT03796806 -
Methods Validation Assessment for Study of Inflammatory Skin Disease
|
||
Completed |
NCT02850601 -
Dexamethasone Solution for the Treatment of Oral Lichen Planus
|
Phase 2 | |
Not yet recruiting |
NCT01041625 -
Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus
|
Phase 2 | |
Completed |
NCT00824889 -
Exploratory Study of Natural Killer Cells in Human Skin
|
N/A |